Venture Capital

The Nexus Forum launches to connect China's booming biotech scene with global pharma, capitalizing on a major shift in worldwide drug discovery and deal-making.

Senti Biosciences advances its AML cell therapy to a registrational trial after FDA meeting and a key discovery that quadruples patient response rates.

With a fresh $25M in funding, GovWell aims to slash bureaucracy and rebuild public trust by overhauling outdated government systems with a modern AI platform.

With a major new financing round, BlueWind Medical is set to expand access to its innovative Revi® System for urgency urinary incontinence.

With $5M in funding, a new defense startup aims to solve the Navy's cost crisis by building affordable interceptors to counter cheap enemy drones.

A US clean tech firm and a UAE emirate are partnering to turn deep rock formations into hydrogen factories, a bold move in the race for clean energy.

Peopoly's new FGF printer slashes costs by up to 90%, making massive, industrial-scale 3D printing accessible to businesses of all sizes.

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

Federal integrator Tyto Athene hires a top AI expert from a rival to lead an aggressive 'AI-first' push for defense and intelligence contracts.

SoundThinking hires Mark43 veteran David Jochim to lead its TechnoLogic division, signaling a strategic push for operational excellence and delivery.

With a new CFO known for big-ticket financing and IPO readiness, clinical-stage OnCusp Therapeutics is gearing up for its next major growth spurt.

As CPG startups face a funding crunch and retail hurdles, one operator-led platform is expanding its 'access-first' model nationwide. Here's why it matters.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.

Fresh off its IPO, Agomab Therapeutics is presenting key data for its new IPF drug, AGMB-447, while courting investors on a multi-conference tour.

Anduril's new partnership with BlueTIDE 2026 offers startups a direct path to integrate their tech into the Lattice AI platform, bypassing old hurdles.

Atamyo's new gene therapy shows remarkable early results, potentially halting a severe, progressive muscular dystrophy that affects children.

With a new VP and expanded partnerships, KIBO Commerce is capitalizing on the region's shift away from legacy tech to its flexible, composable solutions.

Japanese auto software firm Micware hits Nasdaq, raising $22.8M to power next-gen vehicle tech and challenge the industry's global giants.

Industrial AI leader showcases autonomous factory solutions in Kuala Lumpur, aligning with Malaysia's strategy to capture a larger slice of the global chip market.

With 799% revenue growth and major Fortune 10 deals, Energous proves wireless power is no longer a gadget gimmick but essential industrial tech.